Successful Transcatheter Aortic Valve Implantation of a Low-Profile Last-Generation Aortic Bioprosthesis in a Patient With Coarctation of the Aorta.
The application of transcatheter aortic valve implantation (TAVI) in a wider and younger population in the near future makes the need to successfully deal with challenging procedural conditions an imperative. We report a case in which TAVI was successfully conducted in a patient with aortic coarctation using a last-generation low-profile bioprosthesis. Despite the fragile aortic wall and its possible abnormal function, a low-profile (14F) CoreValve Evolute R device (Medtronic, Minneapolis, MN) was implanted through the coarctation without complications. Last-generation, low-profile transcatheter implanted aortic valves provide an additional advantage in patients with structural impediments.